IL231121B
Pharmaceutical composition for treatment of degenerative joint disease
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
48 members in 19 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201161545474 | United States of America | P | |
| 201161561221 | United States of America | P | |
| 2012059455 | United States of America | W |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| US2013090292A1 | United States of America | A1 | |
| CA2846598A1 | Canada | A1 | |
| WO2013055734A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL231121A0 | Israel | A0 | |
| IL231121D0 | Israel | D0 | |
| AU2012323305A1 | Australia | A1 | |
| AU2012323305A2 | Australia | A2 | |
| CN103841987A | China | A | |
| KR20140084101A | Republic of Korea | A | |
| EP2766029A1 | European Patent Office (EPO) | A1 | |
| MX2014003933A | Mexico | A | |
| US2014256642A1 | United States of America | A1 | |
| EA201490735A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2014531471A | Japan | A | |
| US8980834B2 | United States of America | B2 | |
| EP2766029A4 | European Patent Office (EPO) | A4 | |
| HK1198431A | Hong Kong, China | A | |
| HK1198431A1 | Hong Kong, China | A1 | |
| CN103841987B | China | B | |
| US9060968B2 | United States of America | B2 | |
| CN104958752A | China | A | |
| US2015352175A1 | United States of America | A1 | |
| NZ623875A | New Zealand | A | |
| SG10201608103YA | Singapore | A | |
| BR112014007675A2 | Brazil | A2 | |
| US9623072B2 | United States of America | B2 | |
| AU2012323305B2 | Australia | B2 | |
| JP6203734B2 | Japan | B2 | |
| US2017274039A1 | United States of America | A1 | |
| AU2017245341A1 | Australia | A1 | |
| EA028343B1 | Eurasian Patent Organization (EAPO) | B1 | |
| IL231121A | Israel | A | |
| IL231121BThis record | Israel | B | |
| MY167804A | Malaysia | A | |
| MX362164B | Mexico | B | |
| CN104958752B | China | B | |
| US10251930B2 | United States of America | B2 | |
| AU2017245341B2 | Australia | B2 | |
| KR102032400B1 | Republic of Korea | B1 | |
| US2019314448A1 | United States of America | A1 | |
| ZA201403350B | South Africa | B | |
| CA2846598C | Canada | C | |
| EP2766029B1 | European Patent Office (EPO) | B1 | |
| PL2766029T3 | Poland | T3 | |
| EP3721884A1 | European Patent Office (EPO) | A1 | |
| ES2795803T3 | Spain | T3 | |
| US10842847B2 | United States of America | B2 | |
| US2021100873A1 | United States of America | A1 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 231121
- Application
- 231121
Titles2
- English
- Pharmaceutical composition for treatment of degenerative joint disease
- Hebrew
- תכשיר רוקחי לטיפול במחלת מפרקים ניוונית
Classification
- CPC, 9
- A61K38/12
- A61K45/06
- A61K31/495
- A61P19/02
- A61K31/167
- A61K31/405
- A61K31/573
- A61K31/20
- A61K9/0019